Skip to main content
. 2016 Dec 13;9:7503–7513. doi: 10.2147/OTT.S115268

Figure 3.

Figure 3

Progression-free survival evaluation in months, in patients without kinetic alteration of CTCs (CTC1+ and CTC2+) and (CTC1− and CTC2−).

Notes: Continuous line: patients with positive CTC maintenance. Dotted line: patients with negative CTC maintenance (P=0.60).

Abbreviation: CTC, circulating tumor cell.